In recent trading session, Conduit Pharmaceuticals Inc (NASDAQ:CDT) saw 0.67 million shares changing hands at last check today with its beta currently measuring 2.37. Company’s recent per share price level of $0.24 trading at $0.0 or -1.57% at last check today assigns it a market valuation of $17.59M. That most recent trading price of CDT’s stock is at a discount of -10316.67% from its 52-week high price of $25.00 and is indicating a premium of 12.5% from its 52-week low price of $0.21. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 16.27 million shares which gives us an average trading volume of 2.80 million if we extend that period to 3-months.
Conduit Pharmaceuticals Inc (NASDAQ:CDT) trade information
Upright in the red during last session for losing -1.57%, in the last five days CDT remained trading in the green while hitting it’s week-highest on Wednesday, 07/24/24 when the stock touched $0.24 price level, adding 15.79% to its value on the day. Conduit Pharmaceuticals Inc’s shares saw a change of -94.76% in year-to-date performance and have moved 0.04% in past 5-day. Conduit Pharmaceuticals Inc (NASDAQ:CDT) showed a performance of -77.53% in past 30-days. Number of shares sold short was 0.62 million shares which calculate 0.35 days to cover the short interests.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s Major holders
Insiders are in possession of 86.65% of company’s total shares while institution are holding 2.24 percent of that, with stock having share float percentage of 16.81%. Investors also watch the number of corporate investors in a company very closely, which is 2.24% institutions for Conduit Pharmaceuticals Inc that are currently holding shares of the company.
